Cargando…
Human Epidermal Growth Factor Receptor 2 and Estrogen Receptor Status in Respect to Tumor Characteristics in Non-Metastatic Breast Cancer
BACKGROUND: The expressions of estrogen receptor (ER) and cell surface receptor, Tyrosine Kinase Human Epidermal Growth Factor Receptor 2 (HER 2), have emerged as the most important molecular biomarkers determining the breast cancer prognosis. In this study, interactions between ER and HER2 were ass...
Autores principales: | Mirtavoos-Mahyari, Hanifeh, Khosravi, Adnan, Esfahani-Monfared, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153272/ https://www.ncbi.nlm.nih.gov/pubmed/25191491 |
Ejemplares similares
-
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2022) -
Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study
por: Mirtavoos Mahyari, Hanifeh, et al.
Publicado: (2014) -
Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2019) -
Two thymus-related autoimmune disorders: a case report and review of the literature
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2014) -
A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit
por: Khosravi, Adnan, et al.
Publicado: (2018)